NanoVation Therapeutics^TM was recently featured by the online media outlet Biotech TV, which interviewed company co-founders Drs Pieter Cullis and Jay Kulkarni.

The host, BiotechTV founder Brad Loncar, opens the discussion by referring to recent medical applications of lipid nanoparticles (LNPs) as “the scientific achievement of the decade,” noting that “we wouldn’t have RNA vaccines if we didn’t have LNPs.”

In the interview, Dr. Cullis discusses the biotech scene in Vancouver, the high value of basic research, the evolution of LNP development, and NanoVation’s unique approach to overcoming the challenge of using LNPs to deliver payloads to tissues beyond the liver (extra-hepatic delivery). Dr. Kulkarni, in turn, elaborates on the “one-stop-shop” toolbox NanoVation offers its partners, referencing its recent Novo Nordisk partnership as an example, and reflects on emerging areas of focus within the field.

BiotechTV is a web media outlet focused on the biotechnology sector, offering news, stories, and educational videos, and featuring interviews with biotech leaders on industry topics.

Watch the interview with Drs Cullis and Kulkarni.